ArticleCJC open2026
Evaluation of a Community-based Quality Improvement Smoking Cessation Program Using the Ottawa Model During COVID-19.
Article in CJC open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Tobacco smoking remains a major preventable cause of morbidity and mortality worldwide. In Canada, despite substantial declines in national smoking prevalence over the past 2 decades, important regional disparities persist, with some provinces reporting rates above the national average. This study assessed changes in smoking and cessation outcomes among participants in the Prince Edward Island (PEI) Smoking Cessation Program (SCP), adapted from the Ottawa Model for Smoking Cessation (OMSC) during the COVID-19 pandemic. Methods: This pre-post study evaluated the PEI SCP (2019-2021) among participants completing baseline and 6-month follow-up surveys. Primary outcomes were 7-day and 30-day point-prevalence abstinence at 6 months. Results: Of all tobacco users enrolled in the program (n=1,707), a total of 732 (42.9%) responded to both baseline and 6-month surveys. At the 6-month follow-up, 32.2% of participants achieved 7-day point-prevalence abstinence, and 27.5% of responders reported 30-day point-prevalence abstinence. Nicotine dependence level was significantly reduced (p < 0.001), with the proportion of participants in the low Heaviness of Smoking Index (HSI) category increasing from 17.0% at baseline to 48.7% at follow-up. While 66.5% felt that service quality was unaffected by COVID-19, 29.7% reported pandemic-related challenges to quitting, mainly stress (61.0%) and personal life challenges (31.9%). Conclusions: Findings from the PEI SCP showed that about one-third of respondents achieved smoking abstinence at 6 months, despite the COVID-19 pandemic. These results support continued implementation of evidence-based programs like OMSC in community health settings and highlight the program's resilience under constrained healthcare conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.